Key challenges facing athletes in contaminated supplement cases: Discussion on the Ademi decisionClaude Ramoni
In its award issued in the case of the football player, Arijan Ademi, the Court of Arbitration for Sport (CAS) reduced the sanction imposed on the player, a ban for an anti-doping violation, down to two years from four. They ruled that the player demonstrated he had no intent to cheat, but failed to prove that he deserved a further reduction of the sanction for No Significant Fault or Negligence (see below) when using a contaminated product.
A full review of the Ademi case is available here: 'Key challenges facing athletes in contaminated supplement cases: A review of the Arijan Ademi decision'. It is suggested that readers review this piece first before moving onto the analysis below.
This article builds on the above case review by exploring several interesting issues relating to the interpretation and implementation of anti-doping regulations that were highlighted by the CAS panel in their award and reasoning. Specifically, it looks at how the following issues were addressed:
- The prohibition on WADA-accredited laboratories to analyse supplements without a specific request by an anti-doping organisation (Article 4.2 of the Laboratory Code of Ethics);
- Is it necessary to establish the source of the prohibited substance in a sample in order to establish absence of intent to “cheat”? (Article 10.2.3 of the WADA Code);
- The flexible concept of No Significant Fault or Negligence (Article 10.5 of the WADA Code)
...to continue reading register here for free
LawInSport is an independent publisher used by sports lawyers, sports business executives and administrators, athletes and support personnel, academics and students to stay informed of the latest legal issues and developments from the world of sport. It is our mission to improve the accountability, transparency and standard of the administration and governance of sport and the understanding of the law.
Thank you for considering becoming a member of LawInSport, supporting independent media and the promotion well researched, reference and accessible legal information that contributes to greater transparency and accountability in the sport and legal sectors.
This work was written for and first published on LawInSport.com (unless otherwise stated) and the copyright is owned by LawInSport Ltd. Permission to make digital or hard copies of this work (or part, or abstracts, of it) for personal use provided copies are not made or distributed for profit or commercial advantage, and provided that all copies bear this notice and full citation on the first page (which should include the URL, company name (LawInSport), article title, author name, date of the publication and date of use) of any copies made. Copyright for components of this work owned by parties other than LawInSport must be honoured.
- Tags: Court of Arbitration for Sport (CAS) | Croatia | Croatian National Anti-Doping Organization (CITA) | International Standard for Laboratories (ISL) | Laboratory Code of Ethics | Switzerland | UEFA | UEFA Anti-Doping Regulations (UEFA ADR) | UEFA Appeals Body | World Anti-Doping Agency (WADA) | World Anti-Doping Code 2015 (WADA Code)
- Key challenges facing athletes in contaminated supplement cases: A review of the Arijan Ademi decision
- Contaminated supplements and the 2015 WADA Code: the legal principles underlying UKAD v. Williams & Warburton
- The doping risks of modern sports supplements: UKAD v. Williams, Warburton
- How whereabouts requirements operate in five different team sports
About the Author
Claude Ramoni is a Swiss qualified Attorney‐at‐Law specialising in advising and representing clients in the fields of sports and business law. After more than seven years of practice with a major law firm in Lausanne, he joined Libra Law as a founding partner in 2009.